Management of Pulmonary Embolism: Results from the German Chest Pain Unit Registry.

Acute coronary syndrome Chest pain unit Pulmonary embolism Standard operating procedures

Journal

Cardiology
ISSN: 1421-9751
Titre abrégé: Cardiology
Pays: Switzerland
ID NLM: 1266406

Informations de publication

Date de publication:
2021
Historique:
received: 18 09 2020
accepted: 29 11 2020
pubmed: 11 3 2021
medline: 1 9 2021
entrez: 10 3 2021
Statut: ppublish

Résumé

Since 2008, specialized chest pain units (CPUs) were implemented across Germany ensuring structured diagnostics in acute chest pain. This study aims to analyze the management of pulmonary embolism (PE) patients in such certified CPUs. Data were retrieved from 13,902 patients enrolled in the German CPU registry and analyzed for the diagnosis of PE including patient characteristics, critical time intervals, diagnostic workup, treatment, and prognosis. PE patients were compared to the overall CPU patient cohort. Only patients with a complete 3-month follow-up were included. Overall, 1.1% of all CPU patients were diagnosed with PE. Chest pain and dyspnea were the leading symptoms. Patients with PE were older, presented with higher heart rates, and more frequently exhibited signs of heart failure, despite a normal left ventricular function. PE patients showed significantly longer time delays between symptom onset and the first medical contact, while PE patients with chest pain presented earlier than PE patients with dyspnea only. Whereas more PE patients had to be transferred to the intensive care unit, in-CPU mortality and event rates over 3 months were low. This study suggests a certain risk for underdiagnosis and consecutive potential undertreatment of PE patients in German Cardiac Society (GCS)-certified CPUs, which is thought to result from an anticipated focus on patients with acute coronary syndrome (ACS). Public awareness for PE beyond chest pain should be improved. Certified CPUs should be urged to implement strategic pathways for a better simultaneous diagnostic workup of differential diagnosis beyond ACS.

Identifiants

pubmed: 33691308
pii: 000513695
doi: 10.1159/000513695
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

304-310

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Stephan Settelmeier (S)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Duisburg-Essen, Essen, Germany.

Matthias Hochadel (M)

Institute for Myocardial Infarction Research Foundation, Ludwigshafen, Germany.

Evangelos Giannitsis (E)

3rd Department of Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Stavros Konstantinides (S)

Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

Thomas Voigtländer (T)

CCB, Cardioangiologisches Centrum Bethanien, Frankfurt am Main, Germany.

Claus Schmitt (C)

Clinic for Cardiology and Angiology, Municipal Hospital Karlsruhe, Karlsruhe, Germany.

Michael Haude (M)

Medical Clinic I, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany.

Sebastian Kerber (S)

Department of Cardiology, Cardiovascular Centre Bad Neustadt, Bad Neustadt, Germany.

Harald Mudra (H)

Heart and Vascular Center Munich Maffeistrasse and Nymphenburg (Klinikum 3. Orden), München, Germany.

Bernd-Dieter Gonska (BD)

Medical Clinic 3, St. Vincentius Hospital, Karlsruhe, Germany.

Jochen Senges (J)

Institute for Myocardial Infarction Research Foundation, Ludwigshafen, Germany.

Frank Breuckmann (F)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Duisburg-Essen, Essen, Germany, frank.breuckmann@uk-essen.de.

Thomas Münzel (T)

Department of Cardiology, University Medical Center Mainz, Johannes Gutenberg-University Mainz, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH